Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
ADVL1722: A Phase 2, Multicenter, Open- Label Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Subjects with Relapsed/Refractory
Grant
Overview
Affiliation
Overview
Date/time Interval
February 26, 2018
Awarded By
CHILDREN'S HOSPITAL (PHILADELPHIA)
Total Award Amount
0.00
Direct Costs
0.00
Sponsor Award Id
Affiliation
Contributor
Ana Galtarossa Xavier
Investigator
Elizabeth Alva
Investigator
Gregory Friedman M.D.
Investigator
Kimberly Whelan M.D.
Investigator
Wayne Liang
Investigator